Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...

The drug has been authorised to treat adult and paediatric patients with haemophagocytic lymphohistiocytosis (HLH)/MAS in known or suspected Still’s disease, including systemic juvenile idiopathic ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the US Food and Drug Administration ...

Swedish Orphan Biovitrum, the Nordic biotech also known as Sobi, on Friday announced that the U.S. Food and Drug ...

FDA approves Gamifant® (emapalumab-lzsg) as first-ever treatment for adults and children with Macrophage Activation ...

When receiving a diagnosis of a rheumatic musculoskeletal disease (RMD), people need a lot of information. Some need it all ...

The 2025 report on Autoimmune Collaboration & Licensing Deals analyzes 943 agreements from 2016-2025, covering over 30 diseases including MS, RA, lupus, and Crohn’s. Access deal terms, financials, and ...

Attend a concert at every San Diego venue, kayak in the ocean, present at a research conference—these are a few of more than 100 things Amoha Bhale has checked off her "Before I Graduate" bucket list ...

Tyenne ® is indicated for the treatment of several inflammatory and immune diseases, including rheumatoid arthritis (RA), giant cell arteritis (GCA), polyarticular juvenile idiopathic arthritis ...

Systemic juvenile idiopathic arthritis (SJIA) is a more severe form of JIA and can be challenging to diagnose and treat. It takes a toll on children’s physical, social and emotional well-being.

Tofidence is indicated in certain patients for the treatment of moderate to severe rheumatoid arthritis, giant cell arteritis, polyarticular juvenile idiopathic arthritis, systemic juvenile ...

Systemic Juvenile Idiopathic Arthritis Market Outlook 2025-2035: The Systemic Juvenile Idiopathic Arthritis Market reached a value of USD 900 Million in 2024. Looking forward, IMARC Group expects the ...